A detailed history of Virginia Retirement Systems Et Al transactions in Incyte Corp stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 126,825 shares of INCY stock, worth $8.73 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
126,825
Previous 24,125 425.7%
Holding current value
$8.73 Million
Previous $1.5 Million 388.07%
% of portfolio
0.07%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Jan 02, 2024

BUY
$57.77 - $65.93 $5.93 Million - $6.77 Million
102,700 Added 425.7%
126,825 $7.33 Million
Q2 2023

Aug 22, 2023

SELL
$60.95 - $75.51 $597,310 - $739,998
-9,800 Reduced 28.89%
24,125 $1.5 Million
Q1 2023

Jul 11, 2023

BUY
$70.23 - $86.01 $718,101 - $879,452
10,225 Added 43.14%
33,925 $2.45 Million
Q4 2022

May 17, 2023

SELL
$67.18 - $84.11 $665,082 - $832,689
-9,900 Reduced 29.46%
23,700 $1.9 Billion
Q3 2022

May 16, 2023

SELL
$66.18 - $82.86 $1.17 Million - $1.47 Million
-17,700 Reduced 34.5%
33,600 $2.24 Billion
Q1 2022

Apr 21, 2022

SELL
$66.02 - $79.71 $6.56 Million - $7.92 Million
-99,400 Reduced 65.96%
51,300 $4.07 Million
Q4 2021

Feb 03, 2022

SELL
$63.34 - $74.11 $8.73 Million - $10.2 Million
-137,900 Reduced 47.78%
150,700 $11.1 Million
Q3 2021

Oct 21, 2021

BUY
$68.67 - $84.02 $3.78 Million - $4.62 Million
55,000 Added 23.54%
288,600 $19.9 Million
Q2 2021

Aug 13, 2021

SELL
$79.87 - $87.53 $1.2 Million - $1.31 Million
-15,000 Reduced 6.03%
233,600 $19.7 Million
Q1 2021

Apr 30, 2021

BUY
$76.02 - $100.5 $18.9 Million - $25 Million
248,600 New
248,600 $20.2 Million
Q4 2020

Feb 16, 2021

SELL
$80.74 - $97.7 $4.97 Million - $6.01 Million
-61,500 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$85.07 - $109.69 $280,731 - $361,977
3,300 Added 5.67%
61,500 $5.52 Million
Q2 2020

Aug 12, 2020

SELL
$74.18 - $108.93 $9.28 Million - $13.6 Million
-125,100 Reduced 68.25%
58,200 $6.05 Million
Q1 2020

May 12, 2020

SELL
$63.18 - $85.97 $2.25 Million - $3.06 Million
-35,600 Reduced 16.26%
183,300 $13.4 Million
Q4 2019

Jan 27, 2020

SELL
$73.04 - $95.72 $36,520 - $47,860
-500 Reduced 0.23%
218,900 $19.1 Million
Q3 2019

Oct 22, 2019

BUY
$72.82 - $86.52 $6.01 Million - $7.15 Million
82,600 Added 60.38%
219,400 $16.3 Million
Q2 2019

Jul 26, 2019

BUY
$73.52 - $88.7 $5.6 Million - $6.76 Million
76,200 Added 125.74%
136,800 $11.6 Million
Q1 2019

Apr 25, 2019

SELL
$63.56 - $88.17 $953,400 - $1.32 Million
-15,000 Reduced 19.84%
60,600 $5.21 Million
Q4 2018

Feb 07, 2019

BUY
$58.5 - $69.94 $836,550 - $1 Million
14,300 Added 23.33%
75,600 $4.81 Million
Q3 2018

Nov 02, 2018

BUY
$61.75 - $74.23 $277,875 - $334,035
4,500 Added 7.92%
61,300 $4.24 Million
Q2 2018

Aug 03, 2018

BUY
$60.85 - $83.98 $3.46 Million - $4.77 Million
56,800 New
56,800 $3.81 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.3B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.